258 related articles for article (PubMed ID: 24878047)
1. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women.
Hernández JL; Olmos JM; Romaña G; Llorca J; Martínez J; Castillo J; de Juan J; Pérez-Pajares I; Ruiz S; González-Macías J
J Clin Endocrinol Metab; 2014 Sep; 99(9):3304-9. PubMed ID: 24878047
[TBL] [Abstract][Full Text] [Related]
2. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
4. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
5. Influence of vitamin D status on vertebral fractures, bone mineral density, and bone turnover markers in normocalcemic postmenopausal women with high parathyroid hormone levels.
Hernández JL; Olmos JM; Pariente E; Nan D; Martínez J; Llorca J; Valero C; Obregón E; González-Macías J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1711-7. PubMed ID: 23457409
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
7. Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis.
Eviö S; Tiitinen A; Laitinen K; Ylikorkala O; Välimäki MJ
J Clin Endocrinol Metab; 2004 Feb; 89(2):626-31. PubMed ID: 14764773
[TBL] [Abstract][Full Text] [Related]
8. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
[TBL] [Abstract][Full Text] [Related]
9. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
[TBL] [Abstract][Full Text] [Related]
10. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
[TBL] [Abstract][Full Text] [Related]
11. Statins decrease bone turnover in postmenopausal women: a cross-sectional study.
Rejnmark L; Buus NH; Vestergaard P; Andreasen F; Larsen ML; Mosekilde L
Eur J Clin Invest; 2002 Aug; 32(8):581-9. PubMed ID: 12190958
[TBL] [Abstract][Full Text] [Related]
12. Effects of 25-hydroxyvitamin D3 therapy on bone turnover markers and PTH levels in postmenopausal osteoporotic women treated with alendronate.
Olmos JM; Hernández JL; Llorca J; Nan D; Valero C; González-Macías J
J Clin Endocrinol Metab; 2012 Dec; 97(12):4491-7. PubMed ID: 23043189
[TBL] [Abstract][Full Text] [Related]
13. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pleiotropic effect of atorvastatin and rosuvastatin on postmenopausal changes in bone turnover: A randomized comparative study.
Braszak-Cymerman A; Walczak MK; Oduah MT; Ludziejewska A; Bryl W
Medicine (Baltimore); 2024 May; 103(19):e38122. PubMed ID: 38728464
[TBL] [Abstract][Full Text] [Related]
15. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
Lee DY; Jee JH; Cho YY; Jang JY; Yu TY; Kim TH; Hong YJ; Hong WJ; Jin SM; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK
Osteoporos Int; 2017 Apr; 28(4):1377-1384. PubMed ID: 28188454
[TBL] [Abstract][Full Text] [Related]
17. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
[TBL] [Abstract][Full Text] [Related]
18. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
19. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.
Hu W; He J; Fu W; Wang C; Yue H; Gu J; Zhang H; Zhang Z
J Clin Densitom; 2019; 22(2):179-184. PubMed ID: 30228048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]